Skip to content
What Next - What the Hell is a Peptide? episode artwork

Jul 30, 2026 26 min

What Next - What the Hell is a Peptide?

from Slate News

On the heels of the success of GLP-1s like Ozempic, other peptide treatments are flooding the marketplace—and advertising spaces. But even as the Trump administration’s FDA discusses approving more treatments and the businesses selling them proliferate, many peptides are sitting in a legal and medical gray area. So how real - and safe - is this peptide hype? Guest: Kate Knibbs, senior writer at WIRED. Want more What Next? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and across all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen. Podcast production by Rob Gunther, Evan Campbell, Madeline Thames-Ducharme and Patrick Fort. Paige Osburn is the senior supervising producer of What Next and What Next TBD.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

What Next - What the Hell is a Peptide?

0:00 26:37

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Slate News?

This episode is 26 minutes long.

When was this Slate News episode published?

This episode was published on July 30, 2026.

Can I download this Slate News episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.